Tirdzniecība Sumitomo Dainippon Pharma Co., Ltd. - 4506 CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 6.1 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.010936% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.011287% | ||||||||
Nakts laika nodeva | 21:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | JPY | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | Japan | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Sumitomo Pharma Co Ltd ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Iepriekš. aizvērt* | 1095.1 |
Atvērt* | 1100.4 |
Izmaiņas par 1 gadu* | -52.04% |
Dienas Diapazons* | 1081.4 - 1101.5 |
52 ned Diapazons | 624.60-1,171.00 |
Vidējais apjoms (10 dienas) | 1.89M |
Vidējais apjoms (3 mēneši) | 28.52M |
Tirgus Kapitalizācija | 252.75B |
Cenas/Peļņas Attiecība | -100.00K |
Izvietotās Akcijas | 397.29M |
Ieņēmumi | 555.54B |
EPS | -187.55 |
Dividende (Ienesīgums %) | 3.30605 |
Beta | 0.87 |
Nākamās Peļņas Datums | Jul 27, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Jun 30, 2022 | 1086.9 | -13.5 | -1.23% | 1100.4 | 1102.1 | 1080.2 |
Jun 29, 2022 | 1095.1 | 14.1 | 1.30% | 1081.0 | 1096.0 | 1075.0 |
Jun 28, 2022 | 1092.0 | 3.9 | 0.36% | 1088.1 | 1098.2 | 1082.0 |
Jun 27, 2022 | 1074.0 | -9.1 | -0.84% | 1083.1 | 1088.4 | 1069.2 |
Jun 24, 2022 | 1073.2 | 17.0 | 1.61% | 1056.2 | 1073.4 | 1045.2 |
Jun 23, 2022 | 1058.1 | 21.9 | 2.11% | 1036.2 | 1067.2 | 1034.2 |
Jun 22, 2022 | 1033.2 | -9.0 | -0.86% | 1042.2 | 1050.4 | 1031.2 |
Jun 21, 2022 | 1044.1 | -4.4 | -0.42% | 1048.5 | 1060.5 | 1040.1 |
Jun 20, 2022 | 1040.2 | 32.9 | 3.27% | 1007.3 | 1042.2 | 1004.3 |
Jun 17, 2022 | 1016.3 | -13.1 | -1.27% | 1029.4 | 1042.2 | 1016.3 |
Jun 16, 2022 | 1057.2 | 6.9 | 0.66% | 1050.3 | 1070.9 | 1043.4 |
Jun 15, 2022 | 1043.2 | 16.9 | 1.65% | 1026.3 | 1044.6 | 1017.7 |
Jun 14, 2022 | 1039.1 | 3.0 | 0.29% | 1036.1 | 1040.0 | 1020.3 |
Jun 13, 2022 | 1048.2 | -21.0 | -1.96% | 1069.2 | 1070.8 | 1047.2 |
Jun 10, 2022 | 1082.0 | -6.1 | -0.56% | 1088.1 | 1093.2 | 1073.1 |
Jun 9, 2022 | 1106.2 | 11.1 | 1.01% | 1095.1 | 1126.0 | 1095.1 |
Jun 8, 2022 | 1097.1 | 15.9 | 1.47% | 1081.2 | 1101.6 | 1063.2 |
Jun 7, 2022 | 1098.0 | 6.8 | 0.62% | 1091.2 | 1116.6 | 1087.0 |
Jun 6, 2022 | 1095.0 | -3.1 | -0.28% | 1098.1 | 1110.0 | 1091.0 |
Jun 3, 2022 | 1111.9 | 21.8 | 2.00% | 1090.1 | 1125.2 | 1087.1 |
Sumitomo Dainippon Pharma Co., Ltd. Events
Laiks (UTC) (UTC) | Valsts | Notikums |
---|---|---|
Friday, June 23, 2023 | ||
Laiks (UTC) (UTC) 01:00 | Valsts JP
| Notikums Sumitomo Pharma Co Ltd Annual Shareholders Meeting Sumitomo Pharma Co Ltd Annual Shareholders MeetingForecast -Previous - |
Thursday, July 27, 2023 | ||
Laiks (UTC) (UTC) 10:59 | Valsts JP
| Notikums Q1 2024 Sumitomo Pharma Co Ltd Earnings Release Q1 2024 Sumitomo Pharma Co Ltd Earnings ReleaseForecast -Previous - |
Thursday, September 28, 2023 | ||
Laiks (UTC) (UTC) 12:00 | Valsts JP
| Notikums Sumitomo Pharma Co Ltd Sumitomo Pharma Co LtdForecast -Previous - |
Monday, October 30, 2023 | ||
Laiks (UTC) (UTC) 06:00 | Valsts JP
| Notikums Q2 2024 Sumitomo Pharma Co Ltd Earnings Release Q2 2024 Sumitomo Pharma Co Ltd Earnings ReleaseForecast -Previous - |
- Ikgadējs
- Ceturkšņa
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Kopējie ienākumi | 555544 | 560035 | 515952 | 482732 | 459267 |
Ienākumi | 555544 | 560035 | 515952 | 482732 | 459267 |
Cost of Revenue, Total | 178919 | 157116 | 137645 | 129045 | 113553 |
Bruto Peļņa | 376625 | 402919 | 378307 | 353687 | 345714 |
Kopējie Darbības Izdevumi | 632523 | 499801 | 444728 | 399493 | 401383 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 373316 | 220620 | 195978 | 179448 | 178285 |
Pētniecība un Attīstība | 131858 | 94903 | 97241 | 92646 | 102364 |
Depreciation / Amortization | 31742 | 16707 | 11272 | 7858 | |
Neparedzēti Izdevumi (Ienākumi) | -255 | 18795 | 34879 | 6812 | |
Other Operating Expenses, Total | -51570 | -4325 | -21638 | -47797 | -7489 |
Darbības Izdevumi | -76979 | 60234 | 71224 | 83239 | 57884 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | 29059 | 22727 | 6627 | 708 | 7162 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -47920 | 82961 | 77851 | 83947 | 65046 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -96714 | 40600 | 36829 | 35918 | 48627 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -74512 | 56413 | 56219 | 40753 | 48627 |
Neto Ienākumi | -74512 | 56413 | 56219 | 40753 | 48627 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -74512 | 56413 | 56219 | 40753 | 48627 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -74512 | 56413 | 56219 | 40753 | 48627 |
Atšķaidītie Neto Ienākumi | -74512 | 56413 | 56219 | 40753 | 48627 |
Atšķaidītie Ienākumi par Akcijām | 397.292 | 397.303 | 397.294 | 397.295 | 397.297 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -187.55 | 141.99 | 141.505 | 102.576 | 122.395 |
Dividends per Share - Common Stock Primary Issue | 21 | 28 | 28 | 28 | 28 |
Atšķaidītā Normalizētā Peļņa par Akciju | -187.55 | 141.676 | 163.885 | 140.139 | 118.037 |
Mazākuma Interese | 22202 | 15813 | 19390 | 4835 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kopējie ienākumi | 95279 | 140976 | 159413 | 159876 | 127963 |
Ienākumi | 95279 | 140976 | 159413 | 159876 | 127963 |
Cost of Revenue, Total | 39153 | 46925 | 46785 | 46056 | 39292 |
Bruto Peļņa | 56126 | 94051 | 112628 | 113820 | 88671 |
Kopējie Darbības Izdevumi | 154481 | 129838 | 202942 | 145262 | 125957 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 83847 | 79888 | 77556 | 77211 | 60052 |
Pētniecība un Attīstība | 55862 | 26016 | 25558 | 24422 | 27121 |
Neparedzēti Izdevumi (Ienākumi) | 1610 | 54433 | -63 | ||
Other Operating Expenses, Total | -24381 | -24601 | -1390 | -2427 | -445 |
Darbības Izdevumi | -59202 | 11138 | -43529 | 14614 | 2006 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | 9090 | -29980 | 17953 | 31996 | 15372 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -50112 | -18842 | -25576 | 46610 | 17378 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -64087 | -17384 | -43334 | 28091 | 5417 |
Mazākuma Interese | 8077 | 6165 | 4943 | 3017 | 4637 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -56010 | -11219 | -38391 | 31108 | 10054 |
Neto Ienākumi | -56010 | -11219 | -38391 | 31108 | 10054 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -56010 | -11219 | -38391 | 31108 | 10054 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -56010 | -11219 | -38391 | 31108 | 10054 |
Atšķaidītie Neto Ienākumi | -56010 | -11219 | -38391 | 31108 | 10054 |
Atšķaidītie Ienākumi par Akcijām | 397.292 | 397.292 | 397.292 | 397.292 | 397.332 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -140.979 | -28.2387 | -96.6317 | 78.3001 | 25.3038 |
Dividends per Share - Common Stock Primary Issue | 7 | 0 | 14 | 0 | 14 |
Atšķaidītā Normalizētā Peļņa par Akciju | -140.979 | -25.6046 | -7.57516 | 78.3001 | 25.2007 |
- Ikgadējs
- Ceturkšņa
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 381860 | 499521 | 459795 | 364090 | 373268 |
Nauda un Īstermiņa Ieguldījumi | 163652 | 238580 | 223178 | 130425 | 181046 |
Nauda un Ekvivalenti | 143478 | 202984 | 193698 | 101708 | 137296 |
Īstermiņa Ieguldījumi | 20174 | 35596 | 29480 | 28717 | 43750 |
Debitoru Parādu Kopsumma, Neto | 98630 | 151500 | 136060 | 140368 | 119243 |
Accounts Receivable - Trade, Net | 95908 | 141020 | 128569 | 129368 | 116059 |
Total Inventory | 94405 | 99021 | 92215 | 79368 | 66889 |
Other Current Assets, Total | 25173 | 10420 | 8342 | 13929 | 6090 |
Total Assets | 1134740 | 1308010 | 1308130 | 1256530 | 834717 |
Property/Plant/Equipment, Total - Net | 58909 | 64091 | 64966 | 65748 | 59485 |
Property/Plant/Equipment, Total - Gross | 196979 | 187785 | 194962 | 217027 | |
Accumulated Depreciation, Total | -132888 | -122819 | -129214 | -157542 | |
Goodwill, Net | 209415 | 195144 | 176492 | 173464 | 99348 |
Intangibles, Net | 329314 | 398692 | 383406 | 421029 | 171390 |
Long Term Investments | 134007 | 115844 | 193035 | 200923 | 74668 |
Other Long Term Assets, Total | 15195 | 29177 | 23707 | 31280 | 53996 |
Total Current Liabilities | 372694 | 278373 | 278147 | 496498 | 198174 |
Accounts Payable | 52141 | 22455 | 26076 | 25640 | 15498 |
Notes Payable/Short Term Debt | 5025 | 5000 | 270000 | 0 | |
Current Port. of LT Debt/Capital Leases | 90588 | 25832 | 11019 | 9097 | 3697 |
Other Current Liabilities, Total | 229965 | 225061 | 236052 | 191761 | 178979 |
Total Liabilities | 727993 | 700119 | 727557 | 723864 | 336579 |
Total Long Term Debt | 244128 | 254510 | 275526 | 37745 | 29286 |
Long Term Debt | 244128 | 243963 | 263859 | 25020 | 27980 |
Deferred Income Tax | 36505 | 26550 | 28424 | 26768 | |
Other Liabilities, Total | 74633 | 75005 | 77852 | 59663 | 109119 |
Total Equity | 406749 | 607888 | 580570 | 532670 | 498138 |
Common Stock | 22400 | 22400 | 22400 | 22400 | 22400 |
Additional Paid-In Capital | 0 | 16725 | 15855 | 17837 | 15861 |
Retained Earnings (Accumulated Deficit) | 280999 | 514210 | 508677 | 457330 | 431799 |
Treasury Stock - Common | -682 | -681 | -679 | -677 | -674 |
Other Equity, Total | 104032 | 31396 | -4258 | -10338 | -3859 |
Total Liabilities & Shareholders’ Equity | 1134740 | 1308010 | 1308130 | 1256530 | 834717 |
Total Common Shares Outstanding | 397.292 | 397.293 | 397.294 | 397.295 | 397.297 |
Note Receivable - Long Term | 6042 | 5538 | 6726 | 2562 | |
Unrealized Gain (Loss) | 23838 | 38575 | 46118 | 32611 | |
Capital Lease Obligations | 10547 | 11667 | 12725 | 1306 | |
Minority Interest | 33 | 65681 | 67608 | 103190 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 381860 | 578515 | 582874 | 557091 | 499521 |
Nauda un Īstermiņa Ieguldījumi | 163652 | 288261 | 276016 | 265590 | 238580 |
Nauda un Ekvivalenti | 143478 | 265773 | 250551 | 255443 | 202984 |
Īstermiņa Ieguldījumi | 20174 | 22488 | 25465 | 10147 | 35596 |
Debitoru Parādu Kopsumma, Neto | 98630 | 149847 | 181331 | 168821 | 151500 |
Accounts Receivable - Trade, Net | 95908 | 149389 | 181181 | 168664 | 151407 |
Total Inventory | 94405 | 90469 | 109914 | 110114 | 99021 |
Other Current Assets, Total | 25173 | 49938 | 15613 | 12566 | 10420 |
Total Assets | 1134740 | 1371520 | 1407950 | 1422930 | 1308010 |
Property/Plant/Equipment, Total - Net | 58909 | 59471 | 62725 | 61889 | 64091 |
Goodwill, Net | 209415 | 211565 | 230853 | 217830 | 195144 |
Intangibles, Net | 329314 | 357420 | 394932 | 436552 | 398692 |
Long Term Investments | 134007 | 141529 | 104855 | 114350 | 115844 |
Note Receivable - Long Term | 6042 | 6004 | 6551 | 6182 | 5538 |
Other Long Term Assets, Total | 15195 | 17013 | 25162 | 29039 | 29177 |
Total Current Liabilities | 372694 | 309546 | 321134 | 320722 | 278373 |
Accounts Payable | 52141 | 52669 | 57545 | 58721 | 46183 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 5025 | |
Current Port. of LT Debt/Capital Leases | 90588 | 5627 | 5668 | 24908 | 25832 |
Other Current Liabilities, Total | 229965 | 251250 | 257921 | 237093 | 201333 |
Total Liabilities | 727993 | 736368 | 761808 | 749923 | 700119 |
Total Long Term Debt | 244128 | 244087 | 244046 | 244004 | 254510 |
Long Term Debt | 244128 | 244087 | 244046 | 244004 | 243963 |
Capital Lease Obligations | 10547 | ||||
Deferred Income Tax | 36505 | 35786 | 31497 | 29734 | 26550 |
Minority Interest | 33 | 62877 | 72464 | 71404 | 65681 |
Other Liabilities, Total | 74633 | 84072 | 92667 | 84059 | 75005 |
Total Equity | 406749 | 635149 | 646144 | 673010 | 607888 |
Common Stock | 22400 | 22400 | 22400 | 22400 | 22400 |
Additional Paid-In Capital | 0 | 18066 | 17736 | 17087 | 16725 |
Retained Earnings (Accumulated Deficit) | 280999 | 486201 | 500602 | 539085 | 514210 |
Treasury Stock - Common | -682 | -682 | -682 | -681 | -681 |
Unrealized Gain (Loss) | 44148 | 16043 | 22226 | 23838 | |
Other Equity, Total | 104032 | 65016 | 90045 | 72893 | 31396 |
Total Liabilities & Shareholders’ Equity | 1134740 | 1371520 | 1407950 | 1422930 | 1308010 |
Total Common Shares Outstanding | 397.292 | 397.292 | 397.292 | 397.293 | 397.293 |
- Ikgadējs
- Ceturkšņa
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | -96714 | 40600 | 36829 | 35918 | 48627 |
Nauda no Darbības | 10802 | 31239 | 135601 | 46128 | 48711 |
Nauda no Darbības | 41263 | 38348 | 22673 | 17365 | 13976 |
Bezskaidras Naudas Preces | 87168 | 49850 | 52197 | 28869 | 33184 |
Cash Taxes Paid | 25450 | 42331 | 35035 | 25908 | 23463 |
Samaksātie Procenti Naudā | 2424 | 2500 | 2229 | 1526 | 144 |
Izmaiņas Apgrozāmajā Kapitālā | -20915 | -97559 | 23902 | -36024 | -47076 |
Nauda no Ieguldījumu Darbībām | 52419 | -18278 | 8875 | -312684 | -35049 |
Kapitālie Izdevumi | -12742 | -13494 | -10806 | -13351 | -12914 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | 65161 | -4784 | 19681 | -299333 | -22135 |
Nauda no Darbībām ar Finansēšanu | -146817 | -21426 | -57215 | 231081 | -28645 |
Naudas Plūsma Finansēšanas Posteņos | -197436 | -870 | -17335 | -1353 | -4 |
Total Cash Dividends Paid | -11125 | -11126 | -11120 | -13106 | -11122 |
Parādu Izsniegšana (Atkāpšanās), Neto | 61744 | -9430 | -28760 | 245540 | -17519 |
Ārvalstu Valūtas Ietekme | 24090 | 17751 | 4729 | -113 | 4504 |
Neto Izmaiņas Naudā | -59506 | 9286 | 91990 | -35588 | -10479 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -96714 | -32627 | -15243 | 28091 | 40600 |
Cash From Operating Activities | 10802 | 54073 | 29480 | 13189 | 31239 |
Cash From Operating Activities | 41263 | 32089 | 22363 | 11518 | 38348 |
Non-Cash Items | 87168 | 98831 | 98354 | 28138 | 49850 |
Cash Taxes Paid | 25450 | 22120 | 10662 | 7943 | 42331 |
Cash Interest Paid | 2424 | 1395 | 1255 | 216 | 2500 |
Changes in Working Capital | -20915 | -44220 | -75994 | -54558 | -97559 |
Cash From Investing Activities | 52419 | 21687 | 7065 | 22449 | -18278 |
Capital Expenditures | -12742 | -9445 | -5521 | -3959 | -13494 |
Other Investing Cash Flow Items, Total | 65161 | 31132 | 12586 | 26408 | -4784 |
Cash From Financing Activities | -146817 | -33017 | -26650 | -6644 | -21426 |
Financing Cash Flow Items | -197436 | 915 | 694 | 714 | -870 |
Total Cash Dividends Paid | -11125 | -11114 | -5563 | -5488 | -11126 |
Issuance (Retirement) of Debt, Net | 61744 | -22818 | -21781 | -1870 | -9430 |
Foreign Exchange Effects | 24090 | 20046 | 37672 | 23465 | 17751 |
Net Change in Cash | -59506 | 62789 | 47567 | 52459 | 9286 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
Sumitomo Chemical Co Ltd | Corporation | 51.6798 | 205634000 | 0 | 2022-09-30 | LOW |
Nomura Asset Management Co., Ltd. | Investment Advisor | 3.4761 | 13831511 | 5000 | 2023-05-31 | LOW |
Inabata & Co Ltd | Corporation | 3.007 | 11965000 | -1817000 | 2022-09-30 | |
Nippon Life Insurance Company | Insurance Company | 1.9053 | 7581000 | 0 | 2022-09-30 | LOW |
SMBC Trust Bank (Trust) | Corporation | 1.7592 | 7000000 | 0 | 2022-09-30 | LOW |
Nikko Asset Management Co., Ltd. | Investment Advisor/Hedge Fund | 1.7206 | 6846457 | 30200 | 2023-05-31 | LOW |
Daiwa Asset Management Co., Ltd. | Investment Advisor | 1.6361 | 6510216 | -118100 | 2023-05-31 | LOW |
Sumitomo Life Insurance Co. | Insurance Company | 1.4516 | 5776000 | 0 | 2022-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1366 | 4522720 | 36300 | 2023-04-30 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 0.8536 | 3396493 | -84890 | 2023-04-30 | LOW |
JPMorgan Securities Japan Co., Ltd. | Research Firm | 0.8457 | 3365000 | 3365000 | 2022-09-30 | LOW |
Sumitomo Pharma Co., Ltd. Employees | Corporation | 0.7565 | 3010000 | 103000 | 2022-09-30 | |
Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | Investment Advisor | 0.7509 | 2988014 | -62200 | 2023-05-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.6754 | 2687277 | 109192 | 2022-12-31 | LOW |
Aioi Nissay Dowa Insurance Co., Ltd. | Insurance Company | 0.6688 | 2661000 | 0 | 2022-09-30 | LOW |
Ono Pharmaceutical Co Ltd | Corporation | 0.5396 | 2147102 | 0 | 2022-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.5298 | 2108000 | -6400 | 2023-05-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.4249 | 1690700 | 0 | 2023-04-30 | LOW |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 0.3767 | 1498900 | -31900 | 2023-05-31 | LOW |
BlackRock Japan Co., Ltd. | Investment Advisor | 0.3738 | 1487200 | -38300 | 2023-04-30 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group535K+
Tirgotāji
87K+
Ikmēneša aktīvie klienti
$113M+
Ikmēneša ieguldījumu apjoms
$64M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Sumitomo Dainippon Pharma Co., Ltd. Company profile
Par Sumitomo Dainippon Pharma Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd., ir farmācijas uzņēmums. Uzņēmums darbojas četros segmentos. Japānas segmentā ražo un pārdod medicīnas zāles. Ziemeļamerikas segments ražo, izstrādā, iepērk un pārdod ētiskos medikamentus. Ķīnas segments ražo un pārdod ētiskos medikamentus, izmantojot savu konsolidēto meitasuzņēmumu. Pārējā aizjūras nodaļa nodarbojas ar savu produktu izstrādi Eiropā. Uzņēmums nodarbojas arī ar pārtikas materiālu un piedevu, ķīmisko produktu, veterināro zāļu, diagnostikas produktu un dzīvnieku klīniskās patoloģijas pārbaudes pakalpojumu ražošanu, iepirkšanu, pārdošanu un piegādi, ekstraktu ražošanu, kā arī zāļu uzglabāšanu, piegādi un klīnisko pārbaudi.
Industry: | Pharmaceuticals (NEC) |
道修町2-6-8
中央区
OSAKA-SHI
OSAKA-FU 541-0045
JP
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 535 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com